Exclusion testing in pregnancy for Huntington's disease

Area of Science:

• Genetics
• Medical Diagnostics
• Reproductive Medicine

Background:

• Huntington's disease (HD) is a neurodegenerative disorder with a 50% risk for offspring when one parent is affected.
• Prenatal testing aims to identify genetic risk before birth, aiding reproductive decisions.
• Exclusion testing specifically determines if an at-risk individual has inherited the HD gene.

Purpose of the Study:

• To evaluate couple attitudes towards prenatal testing for Huntington's disease (HD).
• To assess the effectiveness of counseling and service organization for prenatal exclusion testing.
• To document potential problems associated with presymptomatic and exclusion testing for HD.

Main Methods:

• DNA analysis was performed on 90 couples with one partner at 50% risk for HD.
• Detailed study of 37 couples included evaluation of attitudes before and after testing.
• Assessment of counseling effectiveness and service organization for prenatal diagnosis.

Main Results:

• Exclusion testing provides valuable prediction for some couples, especially when family history is inconclusive.
• Many couples experienced difficulties understanding the DNA test, highlighting the need for intensive counseling.
• Ethical and organizational challenges were identified, requiring careful prior consideration.

Conclusions:

• Prenatal exclusion testing is a beneficial predictive tool for specific couples facing Huntington's disease risk.
• Effective, intensive counseling is essential to address comprehension issues and ethical concerns.
• The long-term demand for exclusion testing relative to widespread presymptomatic testing remains uncertain.